Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding

Virology

Volumn 374, Issue 2, 2008, Pages 371-380

  Wooldridge, Tonia R ^a   Laimins, Laimonis A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Episomes; Gene regulation; Papillomavirus

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; HISTONE; HISTONE H3; HISTONE H4; OCTAMER TRANSCRIPTION FACTOR 1; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR YY1;

ARTICLE; CELL DIFFERENTIATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DNA MODIFICATION; ENHANCER REGION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMA VIRUS TYPE 31; KERATINOCYTE; LIFE CYCLE; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOSOME; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TRANSCRIPTION INITIATION SITE; WART VIRUS;

BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, VIRAL; HISTONES; HUMANS; KERATINOCYTES; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 31; PAPILLOMAVIRIDAE;

EID: 42649098257     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.12.011     Document Type: Article

References (49)

1. Apt D., Chong T., Liu Y., and Bernard H.U. Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J. Virol. 67 8 (1993) 4455-4463
2. Apt D., Watts R.M., Suske G., and Bernard H.U. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology 224 1 (1996) 281-291
3. Bodily J.M., and Meyers C. Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter. J. Virol. 79 6 (2005) 3309-3321
4. Burd E.M. Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 16 1 (2003) 1-17
5. Butz K., and Hoppe-Seyler F. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J. Virol. 67 11 (1993) 6476-6486
6. Carson A., and Khan S.A. Characterization of transcription factor binding to human papillomavirus type 16 DNA during cellular differentiation. J. Virol. 80 9 (2006) 4356-4362
7. Chiang C.M., Ustav M., Stenlund A., Ho T.F., Broker T.R., and Chow L.T. Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc. Natl. Acad. Sci. U. S. A. 89 13 (1992) 5799-5803
8. Cosma M.P. Ordered recruitment: gene-specific mechanism of transcription activation. Mol. Cell 10 2 (2002) 227-236
9. Cripe T.P., Haugen T.H., Turk J.P., Tabatabai F., Schmid III P.G., Durst M., Gissmann L., Roman A., and Turek L.P. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. EMBO J. 6 12 (1987) 3745-3753
10. del Mar Pena L.M., and Laimins L.A. Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression. J. Virol. 75 20 (2001) 10005-10013
11. Gius D., Grossman S., Bedell M.A., and Laimins L.A. Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18. J. Virol. 62 3 (1988) 665-672
12. Gloss B., Bernard H.U., Seedorf K., and Klock G. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 6 12 (1987) 3735-3743
13. Hoppe-Seyler F., Butz K., and zur Hausen H. Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J. Virol. 65 10 (1991) 5613-5618
14. Hoppe-Seyler F., and Butz K. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J. Virol. 67 6 (1993) 3111-3117
15. Howley P.M. Papillomaviridae: the viruses and their replication. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fundamental Virology. Third ed. (1996), Lippincott-Raven Publishers, Philadelphia, PA 947-978
16. Hubert W.G., and Laimins L.A. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression. J. Virol. 76 5 (2002) 2263-2273
17. Hubert W.G., Kanaya T., and Laimins L.A. DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5′ of the minimal origin. J. Virol. 73 3 (1999) 1835-1845
18. Hummel M., Hudson J.B., and Laimins L.A. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66 10 (1992) 6070-6080
19. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 5532 (2001) 1074-1080
20. Jin L., Yang G.Y., and Auborn K. Differences in C/EBPs in normal tissue and papillomas of the larynx. Cell Prolif. 31 3-4 (1998) 127-138
21. Kanaya T., Kyo S., and Laimins L.A. The 5′ region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1. Virology 237 1 (1997) 159-169
22. Koffa M.D., Graham S.V., Takagaki Y., Manley J.L., and Clements J.B. The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels. Proc. Natl. Acad. Sci. U. S. A. 97 9 (2000) 4677-4682
23. Kukimoto I., Takeuchi T., and Kanda T. CCAAT/enhancer binding protein beta binds to and activates the P670 promoter of human papillomavirus type 16. Virology 346 1 (2006) 98-107
24. Kyo S., Inoue M., Nishio Y., Nakanishi K., Akira S., Inoue H., Yutsudo M., Tanizawa O., and Hakura A. NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region. J. Virol. 67 2 (1993) 1058-1066
25. Kyo S., Tam A., and Laimins L.A. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors. Virology 211 1 (1995) 184-197
26. Longworth M.S., and Laimins L.A. The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J. Virol. 78 7 (2004) 3533-3541
27. Longworth M.S., Wilson R., and Laimins L.A. HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. EMBO J. 24 10 (2005) 1821-1830
28. Maytin E.V., and Habener J.F. Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J. Invest. Dermatol. 110 3 (1998) 238-246
29. Maytin E.V., Lin J.C., Krishnamurthy R., Batchvarova N., Ron D., Mitchell P.J., and Habener J.F. Keratin 10 gene expression during differentiation of mouse epidermis requires transcription factors C/EBP and AP-2. Dev. Biol. 216 1 (1999) 164-181
30. Narlikar G.J., Fan H.Y., and Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108 4 (2002) 475-487
31. Ozbun M.A., and Meyers C. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J. Virol. 72 4 (1998) 2715-2722
32. Pray T.R., and Laimins L.A. Differentiation-dependent expression of E1-E4 proteins in cell lines maintaining episomes of human papillomavirus type 31b. Virology 206 1 (1995) 679-685
33. Ruesch M.N., Stubenrauch F., and Laimins L.A. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J. Virol. 72 6 (1998) 5016-5024
34. Schneider R., Bannister A.J., Myers F.A., Thorne A.W., Crane-Robinson C., and Kouzarides T. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat. Cell Biol. 6 1 (2004) 73-77
35. Sedman J., and Stenlund A. The papillomavirus E1 protein forms a DNA-dependent hexameric complex with ATPase and DNA helicase activities. J. Virol. 72 8 (1998) 6893-6897
36. Sen E., Bromberg-White J.L., and Meyers C. Genetic analysis of cis regulatory elements within the 5′ region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J. Virol. 76 10 (2002) 4798-4809
37. Spink K.M., and Laimins L.A. Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification. J. Virol. 79 8 (2005) 4918-4926
38. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 6765 (2000) 41-45
39. Stubenrauch F., and Laimins L.A. Human papillomavirus life cycle: active and latent phases. Semin. Cancer Biol. 9 6 (1999) 379-386
40. Stubenrauch F., Lim H.B., and Laimins L.A. Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J. Virol. 72 2 (1998) 1071-1077
41. Stunkel W., and Bernard H.U. The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J. Virol. 73 3 (1999) 1918-1930
42. Swindle C.S., and Engler J.A. Association of the human papillomavirus type 11 E1 protein with histone H1. J. Virol. 72 3 (1998) 1994-2001
43. Tan S.H., Leong L.E., Walker P.A., and Bernard H.U. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol. 68 10 (1994) 6411-6420
44. Ustav M., and Stenlund A. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 10 2 (1991) 449-457
45. Wang H., Liu K., Yuan F., Berdichevsky L., Taichman L.B., and Auborn K. C/EBPbeta is a negative regulator of human papillomavirus type 11 in keratinocytes. J. Virol. 70 7 (1996) 4839-4844
46. Wilson R., and Laimins L.A. Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose. Methods Mol. Med. 119 (2005) 157-169
47. Zhang B., Laribee R.N., Klemsz M.J., and Roman A. Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes. Virology 329 1 (2004) 189-198
48. Zhao W., Noya F., Chen W.Y., Townes T.M., Chow L.T., and Broker T.R. Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes. J. Virol. 73 6 (1999) 5026-5033
49. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta 1288 2 (1996) F55-F78